where to be

10+ can't-miss Houston business and innovation events in November

Check out these workshops, networking events, conferences, and other goings on in Houston this month. Photo via Getty Images

This month, Houstonians have yet another good batch of in-person and online innovation events, and you and your tech network need to know about them.

Here's a roundup of virtual events not to miss this month — like demo days, workshops, conventions, and more.

Note: This post might be updated to add more events.

November 3 — Enventure "Inspire" Seminar Series - With Dr. Alyssa Johnston

The "Inspire" Seminar Series was developed by Enventure to help students learn about the reality of working in the biotech and biomedical fields. This particular event will star Dr. Alyssa Johnston, PhD, AstraZeneca Medical Science Liaison. Currently, Alyssa is a MSL at AstraZeneca specializing in GI/GU/Head & Neck Oncology. She is the study lead for a gastric cancer clinical trial, tumor lead for several liver cancer trials, and also works on several IITs. She is the field medical trainer for the pan tumor team and works on sustainability projects including inclusion and diversity projects.

The event is on Wednesday, November 3, at 6 pm. It's free and happening online. Click here to register.

November 4 — The Greentown Labs Climatetech Summit 2021: Empowering the Technology of Tomorrow

The Greentown Labs Climatetech Summit is a deep dive focused on empowering the technology of tomorrow. Climatetech entrepreneurs are developing the solutions that are the core of global decarbonization, yet they need support, cooperation, and collaboration from investors, policymakers, and the growing climatetech workforce in order to scale their critical technologies. The energy transition is here, and the climatetech ecosystem needs your involvement to keep the momentum going.

The event is all day Thursday, November 4. It's free and happening online, or $100 to attend in person at Greentown Houston. Click here to register.

November 8 — Climathon 2021 Awards

Drum roll... and the winning projects of the 2021 Houston Climathon Awards are... going to be revealed soon! Learn More About the Climathon: https://climathonhouston.org

The event is on Monday, November 8, at noon. It's free and happening online. Click here to register.

November 8 — The Cannon + Chevron Open House

Join The Cannon and Chevron for some snacks and learn how Chevron leverages relationships with the start up community to deliver higher returns and lower carbon. Members of Chevron Technology Ventures and the IT function will be available to provide some background on our presence at The Cannon and exchange ideas on partnering opportunities.

The event is on Monday, November 8, at noon. It's free and happening at The Cannon (1300 Brittmoore Rd). Click here to register.

November 9 — BEAMW Networking Launch Event

Business Ecosystem Alliance for Minorities & Women (BEAMW) is a newly launched alliance seeking to reduce barriers women and minority small business owners face. This Networking Launch Event will be the first of a series of networking events designed to bring small business owners, different business support organizations, investors, bankers, and collaborators together to gain valuable information and make key connections.

The event is on Tuesday, November 9, at 6 pm. It's free and happening at The Downtown Launchpad (1801 Main St). Click here to register.

November 10 — Go to Market Strategies with RHIS Group

The Cannon has partnered with the RHIS Group to expand available resources. Join the session on Go to Market Strategies to understand different pillars of strategy, organizational capability, challenges and common perceptions, and strategy development.

The event is on Wednesday, November 10, at 10:30 am. It's free and happening at The Cannon (1300 Brittmoore Rd). Click here to register.

November 10 — Investing in the Energy Transition: ESG and Regulatory Impacts

A key aspect of the energy transition is how industry accounts for long-term strategy and competitive positioning in a constantly evolving landscape. With a sharp focus on regulatory and ESG legal implications, this panel discussion examines how companies will address the marketplace changes – not only with its stakeholders, but within the foundation of their products and procedures as they define value creation toward constituents in the court of global opinion.

The event is on Tuesday, November 16, at 10 am. It's free and happening online. Click here to register.

November 11 — The Listies Gala

Come one, come all to a night celebrating Houston innovation at the Houston Museum of Natural Science. Think "Met Gala meets Houston innovation" and an evening of multicultural Houston food, immersive experiences, and of course HouTech. The host of the evening is Houston's Poet Laureate, Outspoken Bean, who will bring more Houston energy to the Lisites for everyone to enjoy.

The event is on Thursday, November 11, at 7 pm at the Houston Museum of Natural Science. Tickets are $75. Click here to register.

November 16 —  Investing in the Energy Transition: The World of External Investment Finance

As global industry continues to embark on an unparalleled pivot toward sustainable energy, crucial questions have risen regarding the financial risks and rewards of such an intrepid move. What is the role of venture capital? Private equity? Institutional investors? Infrastructure funds? Is moving away from traditional fossil fuels sustainable, and are there adequate channels of investments to fund? In what should be an insightful dialogue on our present position and what must be addressed along the way, this panel poses these queries – and more – toward financial experts to determine industry and societal cost of the energy transition. The goal? To explore the mismatch of opportunity and investment as well as the full range of buy-in – literally and figuratively – that the world must achieve to successfully adapt to the new landscape. Moderated by Ahmad Atwan, CEO of VC Fuel.

The event is on Tuesday, November 16, at 10 am. It's free and happening online. Click here to register.

November 16 — What happens when you talk to an investor?

Steve Jennis of Founder's Compass responds to questions submitted by members of The Cannon Community related to the fundraising process. This online session will be followed by an AMA session for any other questions, clarifications, or points provoked by his answers.

The event is on Tuesday, November 16, at 10 am. It's free and happening online. Click here to register.

November 17 — Illuminate Houston

The Greater Houston Partnership's Young Professionals and Entrepreneurs group, HYPE, invites you to Illuminate Houston - an event series highlighting businesses and thought leaders challenging the way we think about the future. Join for the final Illuminate Houston of 2021 featuring Juliana Garaizar, Head of Houston Incubator and VP, Innovation, Greentown Labs. Don't miss this dynamic conversation where this climatetech startup leader shares insights on Houston's growing innovation ecosystem and leading the way in the global energy transition.

The event is on Wednesday, November 17, at noon. It's $25 for non-members and happening online. Click here to register.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted